CASP3 and movement disorder: The present results indicate that the injection of ACR (50 mg/kg) for 11 days significantly led to movement disorders, decreased GSH content, and increased amounts of MDA, TNF-α, IL-1β, and caspase-3, resulting in the induction of oxidative stress, inflammation, and apoptosis in the brain cortex.